Welcome!

News Feed Item

Influenza Global Clinical Trials Review, H2, 2013



 

 

 

LONDON, March 19, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

Influenza Global Clinical Trials Review, H2, 2013


Influenza Global Clinical Trials Review, H2, 2013


Summary

GlobalData's clinical trial report, "Influenza Global Clinical Trials Review, H2, 2013" provides data on the Influenza clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Influenza. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Influenza. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)


Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Influenza 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Influenza 24
Subjects Recruited Over a Period of Time 31
Prominent Sponsors 32
Top Companies Participating in Influenza Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Novartis AG 49
Clinical Trial Overview of Novartis AG 49
Sanofi 56
Clinical Trial Overview of Sanofi 56
MedImmune, LLC 61
Clinical Trial Overview of MedImmune, LLC 61
F. Hoffmann-La Roche Ltd. 65
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 65
CSL Limited 67
Clinical Trial Overview of CSL Limited 67
Baxter International Inc. 69
Clinical Trial Overview of Baxter International Inc. 69
Daiichi Sankyo Company, Limited 71
Clinical Trial Overview of Daiichi Sankyo Company, Limited 71
Crucell Holland B.V 72
Clinical Trial Overview of Crucell Holland B.V 72
BioCryst Pharmaceuticals, Inc. 73
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 73
Adimmune Corporation 74
Clinical Trial Overview of Adimmune Corporation 74
Sinovac Biotech Co., Ltd. 75
Clinical Trial Overview of Sinovac Biotech Co., Ltd. 75
OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd. 76
Clinical Trial Overview of OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd. 76
Novartis Vaccines and Diagnostics, Inc. 77
Clinical Trial Overview of Novartis Vaccines and Diagnostics, Inc. 77
Novavax, Inc. 78
Clinical Trial Overview of Novavax, Inc. 78
VaxInnate Corporation 79
Clinical Trial Overview of VaxInnate Corporation 79
Protein Sciences Corporation 80
Clinical Trial Overview of Protein Sciences Corporation 80
Abbott Laboratories 81
Clinical Trial Overview of Abbott Laboratories 81
Kaketsuken K.K. 82
Clinical Trial Overview of Kaketsuken K.K. 82
Pfizer Inc. 83
Clinical Trial Overview of Pfizer Inc. 83
Clinical Trial Overview of Top Institutes / Government 84
The National Institute of Allergy and Infectious Diseases 84
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 84
The University of Hong Kong 91
Clinical Trial Overview of The University of Hong Kong 91
University of Oxford 92
Clinical Trial Overview of University of Oxford 92
University Hospitals of Leicester NHS Trust 93
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 93
National Hospital Organization Mie National Hospital 94
Clinical Trial Overview of National Hospital Organization Mie National Hospital 94
Centers for Disease Control and Prevention 95
Clinical Trial Overview of Centers for Disease Control and Prevention 95
St. Jude Children's Research Hospital, Inc. 96
Clinical Trial Overview of St. Jude Children's Research Hospital, Inc. 96
The University of British Columbia 97
Clinical Trial Overview of The University of British Columbia 97
University of the Witwatersrand 98
Clinical Trial Overview of University of the Witwatersrand 98
Program for Appropriate Technology in Health 99
Clinical Trial Overview of Program for Appropriate Technology in Health 99
University of Rochester 100
Clinical Trial Overview of University of Rochester 100
Columbia University 101
Clinical Trial Overview of Columbia University 101
Assistance Publique - Hopitaux de Paris 102
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 102
McMaster University 103
Clinical Trial Overview of McMaster University 103
Institut National de la Sante et de la Recherche Medicale 104
Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 104
Queen Mary Hospital 105
Clinical Trial Overview of Queen Mary Hospital 105
University of Pittsburgh 106
Clinical Trial Overview of University of Pittsburgh 106
Hadassah Medical Organization 107
Clinical Trial Overview of Hadassah Medical Organization 107
University of Michigan 108
Clinical Trial Overview of University of Michigan 108
University of Alberta 109
Clinical Trial Overview of University of Alberta 109
Five Key Clinical Profiles 110
Appendix 161
Abbreviations 161
Definitions 161
Research Methodology 162
Secondary Research 162
About GlobalData 163
Contact Us 163
Disclaimer 163
Source 164




List of Tables

Influenza Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Influenza Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Influenza Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Influenza Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Influenza Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Influenza Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Influenza Therapeutics Clinical Trials, G7 Countries, 2013* 17
Influenza Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Influenza Therapeutics Clinical Trials, E7 Countries, 2013* 19
Influenza Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Influenza Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Influenza Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Influenza Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Influenza Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Influenza Therapeutics Market, Global, Terminated Clinical Trials, 2013* 27
Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 31
Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 33
Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 35
Influenza Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 37
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 49
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 56
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2013* 61
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 65
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2013* 67
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2013* 69
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2013* 71
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Crucell Holland B.V, 2013* 72
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2013* 73
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Adimmune Corporation, 2013* 74
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Sinovac Biotech Co., Ltd., 2013* 75
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd., 2013* 76
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Vaccines and Diagnostics, Inc., 2013* 77
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Novavax, Inc., 2013* 78
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by VaxInnate Corporation, 2013* 79
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Protein Sciences Corporation, 2013* 80
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2013* 81
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaketsuken K.K., 2013* 82
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 83
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 84
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2013* 91
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2013* 92
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2013* 93
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by National Hospital Organization Mie National Hospital, 2013* 94
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2013* 95
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, Inc., 2013* 96
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of British Columbia, 2013* 97
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of the Witwatersrand, 2013* 98
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Program for Appropriate Technology in Health, 2013* 99
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2013* 100
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2013* 101
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 102
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2013* 103
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut National de la Sante et de la Recherche Medicale, 2013* 104
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary Hospital, 2013* 105
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 106
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2013* 107
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2013* 108
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2013* 109

List of Figures
Influenza Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Influenza Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Influenza Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Influenza Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Influenza Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
Influenza Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Influenza Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Influenza Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Influenza Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Influenza Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Influenza Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Influenza Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 31
Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 32
Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 34
Influenza Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36
GlobalData Methodology 162


Read the full report:
Influenza Global Clinical Trials Review, H2, 2013
http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trial...

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"Qosmos has launched L7Viewer, a network traffic analysis tool, so it analyzes all the traffic between the virtual machine and the data center and the virtual machine and the external world," stated Sebastien Synold, Product Line Manager at Qosmos, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Internet-of-Things discussions can end up either going down the consumer gadget rabbit hole or focused on the sort of data logging that industrial manufacturers have been doing forever. However, in fact, companies today are already using IoT data both to optimize their operational technology and to improve the experience of customer interactions in novel ways. In his session at @ThingsExpo, Gordon Haff, Red Hat Technology Evangelist, will share examples from a wide range of industries – includin...
"We build IoT infrastructure products - when you have to integrate different devices, different systems and cloud you have to build an application to do that but we eliminate the need to build an application. Our products can integrate any device, any system, any cloud regardless of protocol," explained Peter Jung, Chief Product Officer at Pulzze Systems, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Keeping pace with advancements in software delivery processes and tooling is taxing even for the most proficient organizations. Point tools, platforms, open source and the increasing adoption of private and public cloud services requires strong engineering rigor – all in the face of developer demands to use the tools of choice. As Agile has settled in as a mainstream practice, now DevOps has emerged as the next wave to improve software delivery speed and output. To make DevOps work, organization...
Get deep visibility into the performance of your databases and expert advice for performance optimization and tuning. You can't get application performance without database performance. Give everyone on the team a comprehensive view of how every aspect of the system affects performance across SQL database operations, host server and OS, virtualization resources and storage I/O. Quickly find bottlenecks and troubleshoot complex problems.
Internet of @ThingsExpo has announced today that Chris Matthieu has been named tech chair of Internet of @ThingsExpo 2017 New York The 7th Internet of @ThingsExpo will take place on June 6-8, 2017, at the Javits Center in New York City, New York. Chris Matthieu is the co-founder and CTO of Octoblu, a revolutionary real-time IoT platform recently acquired by Citrix. Octoblu connects things, systems, people and clouds to a global mesh network allowing users to automate and control design flo...
"We are an all-flash array storage provider but our focus has been on VM-aware storage specifically for virtualized applications," stated Dhiraj Sehgal of Tintri in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
With 15% of enterprises adopting a hybrid IT strategy, you need to set a plan to integrate hybrid cloud throughout your infrastructure. In his session at 18th Cloud Expo, Steven Dreher, Director of Solutions Architecture at Green House Data, discussed how to plan for shifting resource requirements, overcome challenges, and implement hybrid IT alongside your existing data center assets. Highlights included anticipating workload, cost and resource calculations, integrating services on both sides...
Unless your company can spend a lot of money on new technology, re-engineering your environment and hiring a comprehensive cybersecurity team, you will most likely move to the cloud or seek external service partnerships. In his session at 18th Cloud Expo, Darren Guccione, CEO of Keeper Security, revealed what you need to know when it comes to encryption in the cloud.
"We're a cybersecurity firm that specializes in engineering security solutions both at the software and hardware level. Security cannot be an after-the-fact afterthought, which is what it's become," stated Richard Blech, Chief Executive Officer at Secure Channels, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
According to Forrester Research, every business will become either a digital predator or digital prey by 2020. To avoid demise, organizations must rapidly create new sources of value in their end-to-end customer experiences. True digital predators also must break down information and process silos and extend digital transformation initiatives to empower employees with the digital resources needed to win, serve, and retain customers.
"We are the public cloud providers. We are currently providing 50% of the resources they need for doing e-commerce business in China and we are hosting about 60% of mobile gaming in China," explained Yi Zheng, CPO and VP of Engineering at CDS Global Cloud, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
The WebRTC Summit New York, to be held June 6-8, 2017, at the Javits Center in New York City, NY, announces that its Call for Papers is now open. Topics include all aspects of improving IT delivery by eliminating waste through automated business models leveraging cloud technologies. WebRTC Summit is co-located with 20th International Cloud Expo and @ThingsExpo. WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web co...
Between 2005 and 2020, data volumes will grow by a factor of 300 – enough data to stack CDs from the earth to the moon 162 times. This has come to be known as the ‘big data’ phenomenon. Unfortunately, traditional approaches to handling, storing and analyzing data aren’t adequate at this scale: they’re too costly, slow and physically cumbersome to keep up. Fortunately, in response a new breed of technology has emerged that is cheaper, faster and more scalable. Yet, in meeting these new needs they...
When it comes to cloud computing, the ability to turn massive amounts of compute cores on and off on demand sounds attractive to IT staff, who need to manage peaks and valleys in user activity. With cloud bursting, the majority of the data can stay on premises while tapping into compute from public cloud providers, reducing risk and minimizing need to move large files. In his session at 18th Cloud Expo, Scott Jeschonek, Director of Product Management at Avere Systems, discussed the IT and busin...